Related references
Note: Only part of the references are listed.Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth
Marta Zarandi et al.
PEPTIDES (2017)
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2
Paola Catanuto et al.
HORMONES & CANCER (2015)
Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function
Luca Szalontay et al.
CELL CYCLE (2014)
Preclinical efficacy of growth hormone-releasing hormone antagonists for androgen-dependent and castration-resistant human prostate cancer
Cale D. Fahrenholtz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antagonist of GH-releasing hormone receptors alleviates experimental ocular inflammation
Yong Jie Qin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancers
Anna Klukovits et al.
CANCER (2012)
mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
Alexandra Faustino et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases
Ferenc G. Rick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antineoplastic Action of Growth Hormone-Releasing Hormone (GHRH) Antagonists
Agnieszka Siejka et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2012)
GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells
Agnieszka Siejka et al.
CELL CYCLE (2011)
Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia
Ferenc G. Rick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Thyroid Cancer Epidemiology and Prognostic Variables
J. A. Sipos et al.
CLINICAL ONCOLOGY (2010)
A correlation of endocrine and anticancer effects of some antagonists of GHRH
Magdolna Kovacs et al.
PEPTIDES (2010)
Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer
Andrew V. Schally et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase
G. Siriwardana et al.
MOLECULAR ENDOCRINOLOGY (2006)
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
T Kondo et al.
NATURE REVIEWS CANCER (2006)
The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues
A Havt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chronic expression of RET/PTC3 enhances basal and insulin-stimulated Pl3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cells
E Miyagi et al.
MOLECULAR CARCINOGENESIS (2004)
Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor
H Kiaris et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The-expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas
R Busto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers
Z Rekasi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)